Page 7 - Sanket Koul

India-US trade deal: Pharma sees no major change during Section 232 probe

India's pharmaceutical exports to the US are unlikely to see major tariff changes under the interim pact as Section 232 investigations continue, though medical devices may gain from better access

RBI nod to direct bank lending to Reits may expedite asset growth

Industry executives note that REITs raise debt by issuing securities subscribed to by mutual funds and non-banking financial companies (NBFCs)

India may need 2.7 bn sq ft of new academic infrastructure by 2035

India's higher education sector could require nearly 30,000 acres of new campus land and 2.7 billion sq ft of academic infrastructure by 2035, driven by rising enrolments and policy ambitions

Max Healthcare Q3 PAT up 26%, revenue rises 10% despite margin compression

Max Healthcare's Q3 profit rose 26% on higher occupancies and overseas patients, even as margins narrowed due to regulatory changes and expansion costs

Centre mandates drug cos to submit post-approval changes for new drugs

Draft amendment seeks mandatory reporting of manufacturing and quality changes to drug regulator

Medanta Q3FY26 PAT falls 33.5% on labour laws, Noida hospital costs

Depreciation, finance costs from new Noida facility and one-time labour code impact weigh on December-quarter profit

Housing ministry raises EWS housing target under PMAY 2.0 by 350%

Targeted housing under BLC component raised from 111,000 to 500,000 homes in FY27

Delhi emerges as world's most cost competitive student city: Report

Younger demography, infra potential prime India's push to be most strategic higher education growth market globally

Mankind Pharma Q3 PAT up 9.5%, revenue rises 11.5% on chronic drugs sales

Mankind Pharma posted a 9.5 per cent rise in Q3FY26 net profit and 11.5 per cent growth in revenue, driven by strong domestic demand for chronic therapies

Budget 2026: Pharma dept prescribes PLI boost for bulk drug output

FY27 PLI scheme allocation rises 2.24%, aiming to add 500 MT to domestic API production

Budget 2026: Govt targets 30 mn hospital admissions under PMJAY in FY27

The health ministry is targeting a sharp rise in hospital admissions and claims disbursal under PMJAY in FY27, even as the Budget provides only a marginal increase in the scheme's overall allocation

Budget 2026 announcements expected to give indirect boost to realty sector

Industry executives say the Budget's focus on data centres, city economic regions and infrastructure funding for tier 2 and 3 cities could spur demand across industrial, warehousing, office and reside

Union Budget 2026-27: Over ₹1 trillion earmarked for the nation's health

Biopharma Shakti initiative to tackle burden of non-communicable diseases, turn India into global, innovation-led hub

Education Budget jumps to ₹1.39 trillion, school learning gets record push

School education and learning receive their highest-ever allocation as Budget 2026-27 raises overall education spending by over 8 per cent, with higher outlays for KVs, IITs and new initiatives

FM announces ₹10,000 crore scheme to promote biopharma manufacturing

Finance Minister Nirmala Sitharaman announced Mission Biopharma Shakti in the Budget, a five-year ₹10,000 crore programme to build domestic capabilities in biologics, biosimilars and clinical research

Centre proposes amendment to allow drug imports via Navi Mumbai airport

Health Ministry proposes listing Navi Mumbai International Airport as a notified port under drug rules, enabling air import of medicines through the facility

Dr Lal PathLabs Q3 net profit falls 6.4% on new labour code impact

Diagnostics major reports a one-time charge linked to new labour codes even as revenue rose over 10% on higher sample volumes and network expansion

IBM signs 10-year lease for 230,000 sq ft office space in Gurugram

US technology major leases space at Tata Realty's Intellion Park as demand for offices in tier-I cities stays strong and absorption continues to outpace new supply

Economic Survey 2026: Obesity fast becoming a public health challenge

Economic Survey flags rising lifestyle diseases and obesity in India, urging stricter regulation and warning labels on ultra-processed foods to curb health risks

Govt moves to curb cheap penicillin-based drug imports for 1 year

Centre imposes one-year minimum import price on key penicillin inputs to check Chinese dumping and protect domestic bulk drug manufacturing